Prime Medicine, Inc. Deferred Income Tax Liabilities, Net
Prime Medicine, Inc. (PRME) had Deferred Income Tax Liabilities, Net of $134.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2024-05-10
- 2024-03-31: Deferred Income Tax Liabilities, Net $134.00K.
- 2023-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2023-09-30: Deferred Income Tax Liabilities, Net $0.00.
- 2023-06-30: Deferred Income Tax Liabilities, Net $108.00K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2024-03-31 | $134.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $0.00 10-Q · filed 2024-05-10 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-03 |
| 2023-06-30 | $108.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $77.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $279.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $481.00K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $1.24M 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B |